Perspective for the use of adamantane-type drugs for the treatment of cerebrovascular and cardiovascular diseases by D. A. Abaimov, A. A. Shabalina

Get full text

Frequency and risk factors for transient neonatal myasthenia by N. A. Khrushcheva, N. I. Shcherbakova, A. A. Shabalina, M. V. Kostyreva

Get full text

Goals and opportunities of bedside hemostasis screening tests by E. V. Roitman, A. A. Shabalina, M. M. Tanashyan, N. Yu. Dmitrieva

Get full text

Monitoring of Aspirin Therapy in Patients with Cerebrovascular Pathology by M. M. Tanashyan, A. A. Raskurazhev, A. A. Kornilova, A. A. Shabalina, D. A. Abaimov, A. V. Naminov

Get full text

Positive experience of the usage of Rituximab in management of refractory myasthenia gravis in Russia by N. I. Shcherbakova, N. A. Suponeva, V. V. Shvedkov, A. A. Shabalina, M. V. Kostyreva, V. A. Rudnichenko, O. I. Galkina

Get full text